HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of the serum cystatin C values in prediction of indications for hemodialysis in patients with chronic renal failure.

AbstractBACKGROUND:
Indications of dialysis treatment for patients with end-stage renal disease depend on various clinical and laboratory parameters. In this study, we aimed to determine whether standardized serum cystatin C (SCC) equation may be an applicability of marker for dialysis initiation and its relationship to other clearance values among patients with advanced chronic kidney disease.
MATERIALS AND METHODS:
A total of 84 patients (45 males, 39 females) aged 19-89 were evaluated in this study. Hemodialysis was indicated according to clinical and laboratory findings, and estimated glomerular filtration rate (eGFR) was according to four different formulas [MDRD, EpiCKD, Cockcroft Gault formula (CGF) and SCC equation].
RESULTS:
eGFR values of patients in the study were 7.23 ± 3.26, 7.86 ± 3.78, 15.09 ± 10.88 and 11.31 ± 4.54 according to MDRD, EpiCKD, SCC equation and CGF, respectively. There was a positive correlation between MDRD, EpiCKD and CGF, and between EpiCKD and CGF (p < 0.01). Also, statistically significant correlation was found between SCC equation and CGF (p < 0.05).
CONCLUSION:
SCC equation was not seemed to be an appropriate marker for starting dialysis in patients with advanced CKD.
AuthorsDede Sit, Taner Basturk, Süleyman Yildirim, Ferdi Karagoz, Nalan Bozkurt, Ayşegül Gunes
JournalInternational urology and nephrology (Int Urol Nephrol) Vol. 46 Issue 1 Pg. 57-62 (Jan 2014) ISSN: 1573-2584 [Electronic] Netherlands
PMID23749031 (Publication Type: Journal Article)
Chemical References
  • Biomarkers
  • Cystatin C
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers (blood)
  • Cystatin C (blood)
  • Female
  • Glomerular Filtration Rate
  • Humans
  • Kidney Failure, Chronic (blood, physiopathology, therapy)
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Renal Dialysis
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: